By John Lee. Sweden's Newbury Pharmaceuticals AB has signed a ten-year exclusivity agreement with an unnamed Chinese pharmaceutical manufacturer, granting it exclusive rights to register, market and sell a portfolio of 40 products in Iraq. The deal was signed through its subsidiary Newbury Pharmaceuticals S.A. The portfolio centres on injectable medicines for hospital and acute care […]
Swedish Pharma Firm Secures Exclusive Iraq Rights
